Neurogene's market cap is currently $254.33M. The company's EPS TTM is $-1.05; its P/E ratio is ―; Neurogene is scheduled to report earnings on August 11, 2025, and the estimated EPS forecast is $-1.25. See an overview of income statement, balance sheet, and cash flow financials.
